The Saudi Arabia Capital Markets Authority (CMA) Board approved Kesay Clinics Company’s application to register and offer 2,000,000 shares, representing 5% of its share capital, in the Parallel Market. The offering will be limited to Qualified Investors as defined in the CMA’s rules. A prospectus will be published sufficiently in advance of the start of the offering. The CMA noted that prospective investors should conduct their own due diligence and that its approval reflects satisfaction of legal requirements under the Capital Market Law and its Implementing Regulations, not a recommendation to invest. The approval is valid for six months from the CMA Board resolution date and will be deemed cancelled if the offering and listing are not completed within that period.
Saudi Arabia Capital Markets Authority 2025-12-31
Saudi Arabia Capital Markets Authority approves Kesay Clinics 2 million share Parallel Market offering for Qualified Investors
The Saudi Arabia Capital Markets Authority approved Kesay Clinics Company's application to register and offer 2,000,000 shares, representing 5% of its share capital, in the Parallel Market, limited to Qualified Investors. The approval is valid for six months, contingent on completion of the offering and listing within this period.